| Journals Medical Newsletter for Friday May 01, 2026 ( 21 items ) |
|
Blocking two proteins reverses lung scarring in preclinical study
ROANOKE, Virginia, April 30 -- The Fralin Biomedical Research Institute at Virginia Tech posted the following news:
* * *
Blocking two proteins reverses lung scarring in preclinical study
*
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in preclinical models.
A new study in the journal Theranostics, led by senior author Yassine Sassi, assistant profe
more
CAIR-NY Calls on Le Moyne College President to Apologize After Condemnation of Palestinian Poet's Use of Word 'Genocide'
WASHINGTON, May 1 -- The Council on American-Islamic Relations posted the following news release on April 29, 2026:
* * *
CAIR-NY Calls on Le Moyne College President to Apologize After Condemnation of Palestinian Poet's Use of Word 'Genocide'
The New York chapter of the Council on American-Islamic Relations (CAIR-NY), a chapter of the nation's largest Muslim civil rights and advocacy organization, today called on Le Moyne College's President Linda LeMura after her condemnation of a Palestini
more
Case Western Reserve University Economics Professor Helper Testifies Before House Science, Space & Technology Subcommittee
WASHINGTON, May 1 -- The House Science, Space and Technology Subcommittee on Research and Technology released the following testimony by Susan Helper, Carlton professor of economics at the Case Western Reserve University Weatherhead School of Management, from an April 21, 2026, hearing entitled "Robots Made in America: Advancing U.S. Leadership in Manufacturing and Automation":
* * *
Chairman Obernolte, Ranking Member Stevens, and distinguished Members of the Subcommittee, thank you for the op
more
Class Act: Ariel Hernandez-Leyva
ST. LOUIS, Missouri, April 30 -- Washington University in St. Louis posted the following news:
* * *
Class Act: Ariel Hernandez-Leyva
*
For about an hour, Ariel Hernandez-Leyva held a scientific secret. A discovery only he had uncovered.
At the time, more than a decade ago, he was an undergraduate at Yale University, working long hours in a biology lab studying cytokinesis, the final stage of cell division. One spring afternoon, while using a high-resolution fluorescence microscope to obse
more
Dr. Miller-Meeks Introduces Legislation to Reform Medicare Physician Payment System
WASHINGTON, April 30 -- Rep. Mariannette Miller-Meeks, R-Iowa, issued the following news release:
* * *
Dr. Miller-Meeks Introduces Legislation to Reform Medicare Physician Payment System
*
WASHINGTON, D.C. - Congresswoman Mariannette Miller-Meeks, M.D. (IA-01), alongside Congressmen Herb Conaway Jr., M.D. (NJ-03) today introduced the Medicare Physician Data-Driven Performance Payment System Act, legislation to modernize Medicare's physician payment system, reduce burdens on providers, and i
more
Imperial College-London: Mice With Respiratory Infections Could Offer Insights to Help Stop Cancer Spreading
LONDON, England, April 24 (TNSjou) -- Imperial College-London issued the following news:
* * *
Mice with respiratory infections could offer insights to help stop cancer spreading
By Samantha Rey
Studying how mice respond to infection by respiratory viruses may hold the answers to inhibiting the spread of metastatic breast cancer, according to a new study.
Metastatic cancer is when the disease has spread from the area it started to other areas of the body. The lungs are one of the most commo
more
Institute of Cancer Research: Seeing the Immune System in Action - New Imaging Study Sheds Light on Cancer Immunotherapy
LONDON, England, May 1 (TNSjou) -- The Institute of Cancer Research issued the following news:
* * *
Seeing the immune system in action: new imaging study sheds light on cancer immunotherapy
Experts have demonstrated that an innovative, non-invasive imaging technique can be harnessed to monitor oncolytic virotherapy, a rapidly advancing field of cancer treatment.
In a recent study, the researchers successfully used immuno-positron emission tomography (immuno-PET) to track the immune response
more
London School of Hygiene: Health of Care Home Residents Impacted by Heatwaves
LONDON, England, April 30 (TNSjou) -- The London School of Hygiene and Tropical Medicine issued the following news:
* * *
Health of care home residents impacted by heatwaves
England's care sector needs more support to prepare for changing climate, authors say
*
The increasing number and intensity of heatwaves in recent years has significantly impacted the health of care and nursing home residents in England, according to a new study.
The frequency and intensity of projected heatwaves cause
more
New Research Challenges Understanding of mRNA Vaccines and Establishes Innovative Way to Make Them More Effective
NEW YORK, April 29 [Category: BizHospital] -- Mount Sinai Health System posted the following news release:
* * *
New Research Challenges Understanding of mRNA Vaccines and Establishes Innovative Way to Make Them More Effective
*
A new study by researchers at the Icahn School of Medicine at Mount Sinai overturns a longstanding assumption about how mRNA vaccines generate immunity, revealing that certain non-immune cells help determine vaccine effectiveness.
The study, published in the April
more
Nikos Vasilakis appointed associate editor of international journal on viruses
GALVESTON, Texas, April 30 -- The University of Texas Medical Branch issued the following news release:
* * *
Nikos Vasilakis appointed associate editor of international journal on viruses
*
Nikos Vasilakis, PhD, vice chair for research in the Department of Pathology at The University of Texas Medical Branch (UTMB), has been appointed associate editor of the "Invertebrate Viruses" section of Viruses, a leading international, peer-reviewed journal that publishes new research on viruses.
Vas
more
Novel Theranostic Approach for Radioimmunotherapy Achieves Curative Responses in Colorectal Cancer T
RESTON, Virginia, April 30 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
* * *
Novel Theranostic Approach for Radioimmunotherapy Achieves Curative Responses in Colorectal Cancer T
*
Media Contact:
Rebecca Maxey
(703) 652-6772
rmaxey@snmmi.org
umors
Reston, VA (April 30, 2026)- A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a preclinical colore
more
Optical antenna allows in-flight communication between drones using UV light
WASHINGTON, April 30 [Category: Medical] -- Optica, formerly the Optical Society, posted the following news release:
* * *
Optical antenna allows in-flight communication between drones using UV light
*
New antenna design captures and amplifies UV signals over a wide area, maintaining secure links between fast-moving drones and other vehicles
WASHINGTON -Researchers have developed a new optical antenna for wireless ultraviolet (UV) communication that captures and amplifies signals from a bro
more
Researchers Uncover Strategy to Help Exhausted Immune Cells Fight Tumors
LA JOLLA, California, April 30 -- The University of California San Diego campus posted the following news:
* * *
Researchers Uncover Strategy to Help Exhausted Immune Cells Fight Tumors
*
Key Takeaways
* UC San Diego biologists have identified a way to reinvigorate immune system cells, which can become exhausted after fighting disease.
* The break down resembles what occurs in other protein aggregate diseases such as Parkinson's and Alzheimer's.
* Protein recycling malfunctions aft
more
Roche to Present Extensive Data Showcasing Its Industry-leading Ophthalmology Portfolio at ARVO 2026
BASEL, Switzerland, May 1 (TNSrep) -- Roche, a biotech company, issued the following news release on April 30, 2026:
* * *
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
* New real-world data confirm Vabysmo's potent retinal drying in nAMD and DME
* Key data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing treatment burden
* Roche will present more than 45 abstracts at A
more
Study: Immigrants help address the US eldercare shortage
CAMBRIDGE, Massachusetts, April 30 -- The Massachusetts Institute of Technology posted the following news:
* * *
Study: Immigrants help address the US eldercare shortage
*
Good caregivers are often in short supply, but after the Covid-19 pandemic hit the U.S. in early 2020, staff levels at nursing homes dropped by 10 percent. What was a simple personnel shortage has moved closer to being a nursing-care crisis.
"We have an aging population, care for them is labor-intensive, and there are sh
more
Three KU students receive prestigious Goldwater scholarships
LAWRENCE, Kansas, April 30 -- The University of Kansas posted the following news:
* * *
Three KU students receive prestigious Goldwater scholarships
*
LAWRENCE -The University of Kansas has three juniors who were selected to receive the Barry M. Goldwater Scholarship out of more than 1,000 nominees nationwide. KU's 2026 Barry M. Goldwater Scholars are Tatum Aikin, Arthur Benson and Carter Gray.
Congress established the Goldwater scholarship program in 1986 in tribute to the retired U.S. se
more
University College London: Gentler Blood Cancer Treatment Could Boost Survival and Quality of Life
LONDON, England, April 30 -- The University College London posted the following news:
* * *
Gentler blood cancer treatment could boost survival and quality of life
A gentler treatment for children whose leukaemia has come back could boost survival and quality of life, a study led by a UCL academic has found.
The new regime significantly reduces the need for intensive chemotherapy and eliminates deaths linked to treatment in children with relapsed leukaemia.
Led by experts including Dr David
more
University of Montreal: Using Plants to Fight Ebola and COVID-19
MONTREAL, Quebec, April 30 (TNSjou) -- The University of Montreal issued the following news:
* * *
Using plants to fight Ebola and COVID-19
In the lab, scientists at the IRCM have discovered new and promising antiretrovirals in two previously unknown compounds of a plant extract rich in the common flavonoid isoquercitrin.
*
Scientists at the Universite de Montreal's affiliated Montreal Clinical Research Institute (IRCM) have identified a new family of natural molecules with strong antivira
more
Update on FDA Advisory Committee Vote on Camizestrant in Combination With a CDK4/6 Inhibitor for Advanced HR-Positive Breast Cancer
WILMINGTON, Delaware, May 1 -- AstraZeneca, a biopharmaceutical company, issued the following news release:
* * *
Update on FDA Advisory Committee vote on camizestrant in combination with a CDK4/6 inhibitor for advanced HR-positive breast cancer
The US Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) did not reach a majority vote in favor of the benefit risk profile of AstraZeneca's camizestrant in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor (p
more
Virginia Tech: Blocking Two Proteins Reverses Lung Scarring in Preclinical Study
BLACKSBURG, Virginia, May 1 (TNSjou) -- Virginia Tech issued the following news:
* * *
Blocking two proteins reverses lung scarring in preclinical study
A multi-institutional team identifies new approach that could move beyond delaying pulmonary fibrosis to reversing lung scarring.
By John Pastor
A Virginia Tech team has identified a promising new therapeutic strategy for idiopathic pulmonary fibrosis (IPF), showing that blocking two proteins can halt and even reverse lung scarring in prec
more
WTAS: FDA Announces Major Steps to Implement Real-Time Clinical Trials
WASHINGTON, April 30 -- The U.S. Department of Health and Human Services issued the following news release:
* * *
WTAS: FDA Announces Major Steps to Implement Real-Time Clinical Trials
*
Agency unveils real-time trial proofs-of-concept and upcoming pilot program
The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). First, the agency unveiled the successful initiation of two proof-of-
more
|
Sign up to Receive this newsletter every day via email.
